Literature DB >> 22553738

Cod liver oil: a potential protective supplement for human glaucoma.

Wen-Bin Huang1, Qian Fan, Xiu-Lan Zhang.   

Abstract

Glaucoma is one of the leading causes of visual impairment and blindness. Improved knowledge of the pathogenesis of this disease has allowed the exploration of new therapeutic methods. In general, elevated intraocular pressure (IOP), oxidative stress, and vascular insufficiency are accepted as the major risk factors for the progression of glaucoma. Many natural compounds have been found beneficial for glaucoma. Nutritional therapies are now emerging as potentially effective in glaucomatous therapy. One nutritional supplement with potential therapeutic value is cod liver oil, a dietary supplement that contains vitamin A and omega-3 polyunsaturated fatty acids (PUFAs). Vitamin A is important for preserving normal vision and it is a well-known antioxidant that prevents the oxidative damage that contributes to the etiology and progression of glaucoma. Vitamin A is also a crucial factor for maintaining the integrity of conjunctival and corneal ocular surfaces, and preventing the impairment of ocular epithelium caused by topical antiglaucomatous drugs. Omega-3 fatty acids are beneficial for glaucoma patients as they decrease IOP, increase ocular blood flow, and improve optic neuroprotective function. In this article, we propose that cod liver oil, as a combination of vitamin A and omega-3 fatty acids, should be beneficial for the treatment of glaucoma. However, further studies are needed to explore the relationship between cod liver oil and glaucoma.

Entities:  

Keywords:  cod liver oil; glaucoma; omega-3 fatty acids; vitamin A

Year:  2011        PMID: 22553738      PMCID: PMC3340802          DOI: 10.3980/j.issn.2222-3959.2011.06.15

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  37 in total

Review 1.  Current management of glaucoma.

Authors:  Kenneth Schwartz; Donald Budenz
Journal:  Curr Opin Ophthalmol       Date:  2004-04       Impact factor: 3.761

Review 2.  Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.

Authors:  Mahinda Y Abeywardena; Glen S Patten
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2011-09-01       Impact factor: 2.895

Review 3.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

4.  Dietary omega 3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow.

Authors:  Christine T O Nguyen; Bang V Bui; Andrew J Sinclair; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

Review 5.  [Oxidative stress in the trabecular meshwork of POAG].

Authors:  U Welge-Lüssen; K Birke
Journal:  Klin Monbl Augenheilkd       Date:  2010-02-12       Impact factor: 0.700

Review 6.  An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part I.

Authors:  Mark A Moyad
Journal:  Urol Oncol       Date:  2005 Jan-Feb       Impact factor: 3.498

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Corneal and conjunctival changes caused by commonly used glaucoma medications.

Authors:  Robert J Noecker; Lisa A Herrygers; Raana Anwaruddin
Journal:  Cornea       Date:  2004-07       Impact factor: 2.651

9.  A dietary combination of omega-3 and omega-6 polyunsaturated fatty acids is more efficient than single supplementations in the prevention of retinal damage induced by elevation of intraocular pressure in rats.

Authors:  Coralie Schnebelen; Bruno Pasquis; Manuel Salinas-Navarro; Corinne Joffre; Catherine P Creuzot-Garcher; Manuel Vidal-Sanz; Alain M Bron; Lionel Bretillon; Niyazi Acar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-13       Impact factor: 3.117

10.  Optic nerve head blood flow using a laser Doppler velocimeter and haemorheology in primary open angle glaucoma and normal pressure glaucoma.

Authors:  P Hamard; H Hamard; J Dufaux; S Quesnot
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

View more
  4 in total

1.  Association of Dietary Fatty Acid Intake With Glaucoma in the United States.

Authors:  Ye Elaine Wang; Victoria L Tseng; Fei Yu; Joseph Caprioli; Anne L Coleman
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

2.  The effect of omega3 fatty acid supplementation on PPARγ and UCP2 expressions, resting energy expenditure, and appetite in athletes.

Authors:  Sara Moradi; Mohamadreza Alivand; Yaser KhajeBishak; Mohamad AsghariJafarabadi; Maedeh Alipour; Philip D Chilibeck; Beitullah Alipour
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-05-08

Review 3.  Strategies to Reduce Oxidative Stress in Glaucoma Patients.

Authors:  Maria D Pinazo-Duran; Kian Shoaie-Nia; Vicente Zanon-Moreno; Silva M Sanz-Gonzalez; Javier Benitez Del Castillo; Jose J Garcia-Medina
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 4.  Rational Basis for Nutraceuticals in the Treatment of Glaucoma.

Authors:  Luigi Antonio Morrone; Laura Rombola; Annagrazia Adornetto; Maria Tiziana Corasaniti; Rossella Russo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.